| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protara Therapeutics, Inc. (TARA) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 27 sells. TARA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 524.0K | $2.72M | - | |
| CFO | 175.0K | $910.0K | - | |
| Other | 158.0K | $821.6K | - | |
| Other | 94.8K | $493.1K | - | |
| Other | 76.0K | $395.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Marshall Randall | 10% Owner | Sell | 200 | $25.19 | $5,038.00 | - | |
| Aug 17, 2020 | Marshall Randall | 10% Owner | Sell | 2,248 | $25.10 | $56,433.28 | -0.2% | |
| Jul 30, 2020 | Marshall Randall | 10% Owner | Sell | 3,833 | $26.33 | $100,909.86 | -0.2% | |
| Jul 28, 2020 | Marshall Randall | 10% Owner | Sell | 25,935 | $30.48 | $790,611.82 | -0.5% | |
| Jul 24, 2020 | Marshall Randall | 10% Owner | Sell | 2,343 | $26.53 | $62,168.97 | -0.1% | |
| Jul 22, 2020 | Marshall Randall | 10% Owner | Sell | 1,595 | $26.71 | $42,598.19 | - | |
| Jul 20, 2020 | Marshall Randall | 10% Owner | Sell | 4,330 | $26.79 | $116,009.52 | -0.2% | |
| Jul 13, 2020 | Marshall Randall | 10% Owner | Sell | 4,804 | $27.28 | $131,077.04 | -0.4% | |
| Dec 15, 2017 | Burke Steven Keith61 | SVP And Chief Medical Officer | Buy | 12,000 | $1.88 | $22,560.00 | +11.4% | |
| Nov 30, 2017 | Flynn James E62 | Director, *director By Deputization | Sell | 110,557 | $1.75 | $193,474.75 | -100% |